Rikitake Y, Hirata K, Kawashima S, Takeuchi S, Shimokawa Y, Kojima Y, Inoue N, Yokoyama M
First Department of Internal Medicine, Kobe University School of Medicine, 7-5-1, Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan.
Biochem Biophys Res Commun. 2001 Mar;281(5):1291-7. doi: 10.1006/bbrc.2001.4510.
Lysophosphatidylcholine, a component of oxidized low density lipoprotein, is critical for pathological conditions including atherosclerosis. However, the signaling mechanism of lysophosphatidylcholine remains poorly understood. Here we reported that lysophosphatidylcholine induces phosphorylation of p38 and the transcription factors, CREB and ATF-1 with concomitant up-regulation of cyclooxygenase-2 expression in cultured vascular endothelial cells. Lysophosphatidylcholine induced p38 phosphorylation in a time- and concentration-dependent manner partly via pathway depending on protein tyrosine kinase. Both lysophosphatidylcholine-stimulated phosphorylation of CREB and ATF-1 and lysophosphatidylcholine-increased expression of cyclooxygenase-2 mRNA and protein were effectively inhibited by a combination of SB203580 and PD98059, specific inhibitors of p38 and MEK1, respectively, as well as Ro31-8220 and H89, potent inhibitors of MSK1. These results suggest that both p38 and ERK may function as upstream signaling pathways capable of activating CREB and ATF-1 with subsequent induction of cyclooxygenase-2 expression by lysophosphatidylcholine.
溶血磷脂酰胆碱是氧化型低密度脂蛋白的一个组成部分,对包括动脉粥样硬化在内的病理状况至关重要。然而,溶血磷脂酰胆碱的信号传导机制仍知之甚少。在此我们报告,在培养的血管内皮细胞中,溶血磷脂酰胆碱可诱导p38以及转录因子CREB和ATF-1的磷酸化,并伴随环氧合酶-2表达上调。溶血磷脂酰胆碱以时间和浓度依赖的方式诱导p38磷酸化,部分是通过依赖蛋白酪氨酸激酶的途径。SB203580和PD98059分别是p38和MEK1的特异性抑制剂,以及Ro31-8220和H89是MSK1的强效抑制剂,它们的组合有效抑制了溶血磷脂酰胆碱刺激的CREB和ATF-1磷酸化以及溶血磷脂酰胆碱增加的环氧合酶-2 mRNA和蛋白表达。这些结果表明,p38和ERK可能作为上游信号通路,能够激活CREB和ATF-1,随后溶血磷脂酰胆碱诱导环氧合酶-2表达。